ALHC - Alignment Healthcare, Inc.

Alignment Healthcare operates the AVA (Alignment Virtual Assistant) platform, a technology-enabled managed care model that coordinates care for Medicare Advantage members. The business model is a B2B2C health plan partnership structure where Alignment contracts with health plans and provider groups to manage high-risk, complex senior patients on a capitated per-member-per-month basis. Revenue is approximately $2.1B annually, concentrated in California with expansion into North Carolina, Nevada, Arizona, and Florida. The company combines real-time clinical data with its proprietary AVA technology to reduce hospitalizations and total cost of care for its roughly 115,000 at-risk members.

Past Year Trends

• Alignment Healthcare grew full-year 2025 revenue 46.1% YoY to $3.95 billion, driven by 25% membership growth to 236,300 members at year-end 2025, as the company scaled its value-based Medicare Advantage model across California, Nevada, and Texas. (Bullish)
• ALHC's adjusted EBITDA surged to $110 million in full-year 2025 from $1 million in 2024, while net loss narrowed to $1.0 million from $128.1 million, reflecting a 130-basis-point improvement in Medical Benefits Ratio to 87.5% and SG&A leverage falling from 11.1% to 9.7% of revenue. (Bullish)
• Alignment Healthcare launched a co-branded $0-premium, 5-star Medicare Advantage plan with Intermountain Health in Clark County, Nevada in October 2025, expanding Nevada market presence to 8 plans covering 520,000+ Medicare-eligible adults and driving 31% YoY membership growth to 275,300 members as of January 1, 2026. (Bullish)

Next Year Trends

• ALHC's 2026 revenue guidance of $5.14–$5.19 billion (roughly 30% YoY growth) and membership guidance of 290,000–296,000 members depend heavily on continued CMS Medicare Advantage rate adequacy; any unfavorable CMS benchmark rate adjustment in the 2027 rate notice could compress margins against an already-thin 87.7% targeted Medical Benefits Ratio. (Bearish)
• A Q1 2026 utilization-management workflow error that caused a non-recoverable $2 million charge from incorrectly paying observational cases at acute rates signals operational scaling risk as membership approaches 300,000; further systems or workflow failures at this growth rate could materially impact the 87.7% MBR guidance midpoint for full-year 2026. (Bearish)
• ALHC's 2026 adjusted EBITDA guidance of $138–$163 million represents continued margin expansion from the $110 million 2025 base, supported by 100% of members enrolled in 4-star-or-higher plans and the California HMO's 9-consecutive-year 5-star rating, which enables preferential CMS bonus payments and marketing advantages during the October–December 2026 Annual Enrollment Period for 2027 coverage. (Bullish)

Red Flags

(b) Securities fraud class action investigations: Multiple plaintiff law firms — including Pomerantz Law Firm, Bronstein Gewirtz & Grossman, Levi & Korsinsky, and Andrews & Springer — announced investigations into Alignment Healthcare (ALHC) for potential securities fraud, triggered by a February 27, 2024 earnings miss (Q4 2023 EPS of -$0.25 vs. consensus -$0.22) that caused the stock to drop ~18% on February 28, 2024; allegations center on whether the company and certain officers made materially false or misleading statements to investors (sources: Business Wire / GlobeNewswire, February–March 2024). Note: these are plaintiff-firm solicitation announcements of investigations, not confirmed filed and certified class action lawsuits; no SEC or DOJ investigation was identified. Categories (a), (c), (d), and (e) have no confirmed flags as of August 2025.